Data / Form D filings / Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc.: Form D filing
Seaport Therapeutics, Inc., a biotechnology company in Boston, MA, filed a Form D with the SEC in 2024. The latest, on October 31, 2024, reports $225.9 million sold of a $226 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6 TIDE STREET, SUITE 400, Boston, MA, 02110
- Phone
- (617) 807-4062
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2042347
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 31, 2024 | New notice | $225,999,937 | $225,899,940 | $99,997 | 33 | Oct 18, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James I. Healy | Director | |
| Michael Chen | Executive Officer | |
| Lana Gladstein | Executive Officer | |
| Daphne Zohar | Executive Officer, Director | |
| Antony Loebel | Executive Officer | |
| David I. Wheadon | Director | |
| Eric Green | Executive Officer | |
| Robert I. Nelsen | Director | |
| Steven Paul | Director | |
| Bharatt I. Chowrira | Director | |
| Denice I. Torres | Director | |
| Eric Elenko | Director | |
| Jason I. Pitts | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Oct 28, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Seaport Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.